                         SEQUENCE LISTING

<110>  Santaris Pharma A/S
 
<120>  HCV COMBINATION THERAPY

<130>  1129 WO

<150>  US 61/502884
<151>  2011-06-30

<150>  US 61/566027
<151>  2011-12-02

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  22
<212>  RNA
<213>  homo sapiens

<400>  1
uggaguguga caaugguguu ug                                                22


<210>  2
<211>  15
<212>  DNA
<213>  artificial

<220>
<223>  Miravirsen nucleobase sequence

<400>  2
ccattgtcac actcc                                                        15


<210>  3
<211>  15
<212>  DNA
<213>  artificial

<220>
<223>  Scambled control oligo nucleobase sequence

<400>  3
tcatactata tgaca                                                        15


<210>  4
<211>  85
<212>  RNA
<213>  homo sapiens

<400>  4
ccuuagcaga gcuguggagu gugacaaugg uguuuguguc uaaacuauca aacgccauua       60

ucacacuaaa uagcuacugc uaggc                                             85


